Option Care Health (NASDAQ:OPCH) vs. Bioqual (OTCMKTS:BIOQ) Head-To-Head Review

Bioqual (OTCMKTS:BIOQ) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Profitability

This table compares Bioqual and Option Care Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bioqual	1.56%	2.01%	1.30%
Option Care Health	3.78%	17.89%	7.20%

Volatility and Risk

Bioqual has a beta of -0.18, suggesting that its share price is 118% less volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500.

Institutional and Insider Ownership

98.1% of Option Care Health shares are held by institutional investors. 39.2% of Bioqual shares are held by company insiders. Comparatively, 0.6% of Option Care Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Bioqual and Option Care Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioqual	$48.87 million	0.69	-$1.05 million	$0.81	46.54
Option Care Health	$5.00 billion	1.09	$211.82 million	$1.26	27.25

Option Care Health has higher revenue and earnings than Bioqual. Option Care Health is trading at a lower price-to-earnings ratio than Bioqual, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Bioqual and Option Care Health, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bioqual	0	0	0	0	0.00
Option Care Health	0	2	10	1	2.92

Option Care Health has a consensus target price of $37.46, suggesting a potential upside of 9.12%. Given Option Care Health’s stronger consensus rating and higher possible upside, analysts plainly believe Option Care Health is more favorable than Bioqual.

Summary

Option Care Health beats Bioqual on 13 of the 15 factors compared between the two stocks.

About Bioqual

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

About Option Care Health

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.